Search Results - "Koskela, Sirpa"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Coagulopathy in Acute Puumala Hantavirus Infection by Koskela, Sirpa, Mäkelä, Satu, Strandin, Tomas, Vaheri, Antti, Outinen, Tuula, Joutsi-Korhonen, Lotta, Pörsti, Ilkka, Mustonen, Jukka, Laine, Outi

    Published in Viruses (06-08-2021)
    “…Puumala hantavirus (PUUV) causes a hemorrhagic fever with renal syndrome (HFRS), also called nephropathia epidemica (NE), which is mainly endemic in Europe and…”
    Get full text
    Journal Article
  3. 3

    Endothelial Nitric Oxide Synthase G894T Polymorphism Associates with Disease Severity in Puumala Hantavirus Infection by Koskela, Sirpa, Laine, Outi, Mäkelä, Satu, Pessi, Tanja, Tuomisto, Sari, Huhtala, Heini, Karhunen, Pekka J, Pörsti, Ilkka, Mustonen, Jukka

    Published in PloS one (11-11-2015)
    “…Hantavirus infections are characterized by both activation and dysfunction of the endothelial cells. The underlying mechanisms of the disease pathogenesis are…”
    Get full text
    Journal Article
  4. 4

    Diminished coagulation capacity assessed by calibrated automated thrombography during acute Puumala hantavirus infection by Koskela, Sirpa M, Joutsi-Korhonen, Lotta, Mäkelä, Satu M, Huhtala, Heini, Vaheri, Antti I, Pörsti, Ilkka, Mustonen, Jukka T, Laine, Outi K

    Published in Blood coagulation & fibrinolysis (01-01-2018)
    “…Coagulation abnormalities are associated with Puumala-virus-induced hemorrhagic fever with renal syndrome (PUUV–HFRS). We evaluated the coagulation capacity of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia by Laine, Outi K, Koskela, Sirpa M, Outinen, Tuula K, Joutsi-Korhonen, Lotta, Huhtala, Heini, Vaheri, Antti, Hurme, Mikko A, Jylhävä, Juulia, Mäkelä, Satu M, Mustonen, Jukka T

    Published in Blood coagulation & fibrinolysis (01-09-2014)
    “…Thrombocytopenia and altered coagulation characterize all hantavirus infections. To further assess the newly discovered predictive biomarkers of disease…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Spleen enlargement is a common finding in acute Puumala hantavirus infection and it does not associate with thrombocytopenia by Koskela, Sirpa M., Laine, Outi K., Paakkala, Antti S., Mäkelä, Satu M., Mustonen, Jukka T.

    “…Abstract The pathogenesis of thrombocytopenia in Puumala hantavirus (PUUV) infection is probably multifactorial. We aimed to evaluate the possible spleen…”
    Get full text
    Journal Article
  11. 11

    Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant by Laine, Outi, Leppänen, Ilona, Koskela, Sirpa, Antonen, Jaakko, Mäkelä, Satu, Sinisalo, Marjatta, Vaheri, Antti, Mustonen, Jukka

    Published in Infectious diseases (London, England) (01-02-2015)
    “…Abstract Early identification of patients at risk of a severe course of hantaviral disease and lack of effective medication represent a global challenge in the…”
    Get full text
    Journal Article
  12. 12

    Endothelial Nitric Oxide Synthase G894T Polymorphism Associates with Disease Severity in Puumala Hantavirus Infection: e0142872 by Koskela, Sirpa, Laine, Outi, Maekelae, Satu, Pessi, Tanja, Tuomisto, Sari, Huhtala, Heini, Karhunen, Pekka J, Porsti, Ilkka, Mustonen, Jukka

    Published in PloS one (01-11-2015)
    “…Introduction Hantavirus infections are characterized by both activation and dysfunction of the endothelial cells. The underlying mechanisms of the disease…”
    Get full text
    Journal Article
  13. 13

    Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant by Laine, Outi, Leppänen, Ilona, Koskela, Sirpa, Antonen, Jaakko, Mäkelä, Satu, Sinisalo, Marjatta, Vaheri, Antti, Mustonen, Jukka

    Published in Infectious Diseases (01-02-2015)
    “…Early identification of patients at risk of a severe course of hantaviral disease and lack of effective medication represent a global challenge in the…”
    Get full text
    Report